Sen. Grassley Rejects PhRMA's Complaints About "Whistleblower" Law
This article was originally published in The Pink Sheet Daily
Executive Summary
In letters to PhRMA and the HHS Inspector General, finance chief rebukes trade association for being "out of tune" with its members on the False Claims Act. PhRMA asserts the FCA "stacks the deck" against drug makers in litigation and discourages internal complaints.